VIRTUAL MIND (01520): The AI creation and intelligent agent platform DolphinOne has officially launched version 2.0.
VIRTUAL MIND (01520) announced that DolphinOne, the AI creation and intelligent agent platform developed by its subsidiary Dolphinode, has officially launched version 2.0.
VIRTUAL MIND (01520) announced that DolphinOne, an AI creation and intelligent agent platform developed by its subsidiary Dolphinode, has officially launched version 2.0.
DolphinOne version 2.0 has been listed globally on the Apple App Store, marking the Group's further advancement of market promotion and commercialization exploration of its multimodal AI platform; actual available functions are subject to the relevant version, region, and service availability arrangements.
DolphinOne is positioned as a Multimodal AI creation and intelligent agent platform, with multi-model integration and application scenario development as its core direction. It plans to continuously expand platform functions and third-party model access capabilities, gradually building a scalable AI application ecosystem. The previously launched version 1.0 mainly focused on basic technical logic and feasibility function research, and was opened to specific users and creative partners on an invitation-only basis. DolphinOne 2.0 further integrates multiple mainstream AI models and generative AI services, continuing to build out multimodal applications including image generation, video creation, music generation, DIGIHUMAN, and intelligent agents, aiming to provide individual creators with a one-stop AI creation and application experience and to provide a technical foundation for expanding enterprise content creation applications. Each function will be advanced in phases according to development, testing, and service availability arrangements.
Related Articles

HK Stock Market Move | FAIRWOOD HOLD (00052) rises over 8% after profit alert, expects interim profit to increase by up to approximately 160% year-on-year

Goldman Sachs: HANSOH PHARMA (03692) Expands ADC Collaboration with Roche, Enhancing Visibility for Global Value Realization; Target Price HK$52.7

HK Stock Market Move | MICOT PHARMA-B (02335) falls back over 20%; the company announces equity incentive and share repurchase plans; existing funds are sufficient to support R&D investment.
HK Stock Market Move | FAIRWOOD HOLD (00052) rises over 8% after profit alert, expects interim profit to increase by up to approximately 160% year-on-year

Goldman Sachs: HANSOH PHARMA (03692) Expands ADC Collaboration with Roche, Enhancing Visibility for Global Value Realization; Target Price HK$52.7

HK Stock Market Move | MICOT PHARMA-B (02335) falls back over 20%; the company announces equity incentive and share repurchase plans; existing funds are sufficient to support R&D investment.






